Clinical trials: Hair Problems
Hair Thinning
Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females
A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair.
- Trial name
- NCT06376409
- Testing
- Nutrafol Women's Hair Growth Supplement, Nutrafol Women's Balance Hair Growth Supplement, Nutrafol Women's Vegan Hair Growth Supplement
- Where
- United States
- Volunteers
- 181 people, healthy volunteers welcome
- Sponsor
- Nutraceutical Wellness Inc.
Androgenetic Alopecia
A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia
To investigate the efficacy of HMI-115 compared to placebo in treating Androgenic Alopecia patients for 24 weeks
- Trial name
- NCT06118866
- Testing
- HMI-115-120mg-Q4W, HMI-115-240mg-Q4W, HMI-115, 240mg-Q2W
- Where
- China
- Volunteers
- 192 people
- Sponsor
- Hope Medicine (Nanjing) Co., Ltd
Androgenetic Alopecia, Male Pattern Baldness
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
The purpose of the the study is to evaluate the ability of injections of Ji Gami(TM) C to induce hair growth in male and female subjects with hair loss.
- Conditions
- Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Baldness
- Trial name
- NCT01451151
- Testing
- Autologous cultured dermal and epidermal cells
- Where
- 2 sites in United States
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Aderans Research Institute
Hair Thinning
Efficacy and Tolerability of a Scalp Serum
The goal of this clinical trial is to evaluate the efficacy and tolerability of a scalp serum on 60 healthy females aged 25 to 65 years with Fitzpatrick skin phototypes I-VI and with mild to moderate thinning hair.
- Trial name
- NCT07500623
- Testing
- Scalp Serum
- Where
- United States
- Volunteers
- 57 people
- Sponsor
- Revision Skincare
Androgenetic Alopecia (AGA)
To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia
This study is a multicenter, randomized, double-blind, vehicle controlled, adaptive design phase 2/3 study to evaluate the efficacy and safety of topical KX-826 solution in Chinese male patients with androgenetic alopecia (AGA).
- Trial name
- NCT06622824
- Testing
- KX-826 0.5% BID, KX-826 1.0% BID
- Where
- China
- Volunteers
- 756 people
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
Hair Loss/Baldness, Androgenic Alopecia
Effect of the Composition From Fish on Promoting Hair Growth
According to the World Health Organization data, one out of every five Chinese men has a hair loss symptom, and the hair loss is as high as 84% before the age of 30.
- Conditions
- Hair Loss/Baldness, Androgenic Alopecia, Male Pattern Baldness, Female Pattern Alopecia
- Trial name
- NCT05450861
- Testing
- SF DNA extraction composition
- Where
- Taiwan
- Volunteers
- 53 people
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Hypertrichosis
Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo
Aim of the study is to evaluate clinically and by non-invasive instrumental evaluations the activity on hair regrowth of a topical cosmetic product versus placebo (comparison within subjects)
- Trial name
- NCT03273504
- Testing
- Actapil Corpo Spray (SHEDIR PHARMA Srl - Italy)
- Where
- Italy
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Derming SRL
Androgenetic Alopecia
A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
This is a multi-centers, randomized, double-blind, parallel-group, Phase 2 Trial to evaluate the efficacy and safety of CKD-498 in female patients with Androgenetic Alopecia
- Trial name
- NCT05677438
- Testing
- CKD-498 dose#1, CKD-498 dose#2, CKD-498 dose#3
- Where
- South Korea
- Volunteers
- 121 people
- Sponsor
- Chong Kun Dang Pharmaceutical
Alopecia, Lichen Planus
Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
The prevalence of pruritus has been studied in frontal fibrosis alopecia (FFA) and lichen planus pilaris (LPP), but there are no studies evaluating the characteristics of pruritus, the correlation between pruritus and disease…
- Trial name
- PRURIT-ALOPECI (NCT05761158)
- Testing
- questionnaire
- Where
- France
- Volunteers
- 21 people
- Sponsor
- University Hospital, Brest
Hair Loss
Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females
The objective of this study is to assess the safety and effectiveness of a nutraceutical supplement for the treatment of hair loss and thinning in females over the course of six months of continuous daily use.
- Trial name
- NCT03052413
- Testing
- Nutrafol
- Where
- 2 sites in United States
- Volunteers
- 21 people
- Sponsor
- Sadick Research Group
Alopecia Areata
Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata
The goal of this clinical research study is to find the most effective dose of Targretin® (bexarotene) Gel 1% that can be given to patients as a treatment for alopecia areata.
- Trial name
- NCT00063076
- Testing
- Targretin Gel 1%
- Where
- United States
- Volunteers
- 46 people, healthy volunteers welcome
- Sponsor
- M.D. Anderson Cancer Center
Alopecia Areata
A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata
The use of topical steroids in the treatment of alopecia areata in children is common practice. However, no particular potency of steroid is accepted as the standard treatment due to the paucity of high quality evidence in the…
- Trial name
- NCT01453686
- Testing
- Hydrocortisone 1%, Clobetasol Propionate 0.05%
- Where
- Canada
- Volunteers
- 41 people
- Sponsor
- The Hospital for Sick Children
Alopecia
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
This Phase 2, multicenter, randomized study will evaluate the safety, tolerability and efficacy of ATI-501 for the treatment of Alopecia Areata (AA), Alopecia Universalis (AU) or Alopecia Totalis (AT) in adult subjects.
- Trial name
- NCT03594227
- Testing
- ATI-501 400mg BID (Low dose), ATI-501 600mg BID (Mid dose), ATI-501 800mg BID (High dose)
- Where
- 25 sites in United States
- Volunteers
- 87 people, healthy volunteers welcome
- Sponsor
- Aclaris Therapeutics, Inc.
Androgenetic Alopecia, Male Pattern Baldness
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)
To evaluate the ability of injections of Ji Gami(TM) and Ji Gami(TM) DO to induce hair growth in male and female subjects with hair loss
- Conditions
- Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Baldness
- Trial name
- NCT01451047
- Testing
- Autologous cultured dermal and epidermal cells
- Where
- 7 sites in United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Aderans Research Institute
Androgenic Alopecia
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
- Trial name
- NCT04341363
- Testing
- Tattoo machine
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Yale University
Hirsutism
Bone Status and Insulin Resistance in Hirsutism
The purpose of this study is to investigate how the bones of hirsute women are different from bones of healthy women. The change in hormone content in the blood will also be investigated.
- Trial name
- NCT00143052
- Where
- Denmark
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Odense University Hospital
Dihydrotestosterone, Testosterone
Influence of Creatine Monohydrate Supplementation on Androgens and Global Hair Assessments
This study is a randomized, double-blind, placebo-controlled trial examining the effects of creatine monohydrate supplementation on androgens and hair loss in free-living adult males.
- Conditions
- Dihydrotestosterone, Testosterone, Hair Loss
- Trial name
- NCT04298840
- Testing
- Creatine Monohydrate Supplementation
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Texas Tech University
Androgenic Alopecia
Microneedling for Androgenic Alopecia: a Clinical Study
A total of 20-30 patients with mild to moderate androgenic alopecia are expected to be enrolled. Inclusion criteria are patients aged ≥22 years; for males, Norwood's grading II-IV, and for females, Ludwig stage I-II.
- Trial name
- NCT07580521
- Testing
- Microneedling monotherapy without drugs
- Where
- Taiwan
- Volunteers
- 25 people
- Sponsor
- Taipei Medical University WanFang Hospital
Cushing's Syndrome
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Participants in study C-1073-400 (NCT00569582) will be invited to participate in this extension study to examine the long term safety of mifepristone in the treatment of the signs and symptoms of endogenous Cushing's syndrome.
- Trial name
- NCT00936741
- Testing
- mifepristone
- Where
- 15 sites in United States
- Volunteers
- 30 people
- Sponsor
- Corcept Therapeutics
Androgenetic Alopecia
Pharmacogenomic Study of Androgenetic Alopecia
Androgenic alopecia, the common form of hair loss is a highly heritable disorder of considerable social significance affecting around 40% of adult men and women.
- Trial name
- NCT01227031
- Where
- Taiwan
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- Taipei Medical University WanFang Hospital